Potassium Dichromate
US-FDASourced from openFDA
GET
/api/v1/drug/potassium-dichromateIndications
Sourced from openFDA- Uses: Use the leaflet enclosed for detail.
Dosage & administration
Sourced from openFDAFor best results, do this: Take 3-5 tablets 3-4 times a day. If you weigh less than 100 lbs, use half a dose or take it as prescribed. Contraindications: Traditional Homeopathic formulations do not interact with other remedies, herbs, or other supplements.
Warnings & precautions
Sourced from openFDAand Storage: Ask a professional before use if pregnant or breast feeding or if you have severe symptoms. Keep away from children. If you have a reaction to this product that is not positive, discontinue use. Store in a cool and dry place. Packaging: 30gm jar standard quality packing.
FAERS reports
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
518 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
- 1Diarrhoea366.9%
- 2Headache366.9%
- 3Pain366.9%
- 4Fatigue356.8%
- 5Nausea336.4%
- 6Arthralgia285.4%
- 7Dizziness275.2%
- 8Pain In Extremity234.4%
- 9Abdominal Pain Upper224.2%
- 10Asthenia214.1%
- 11Fall214.1%
- 12Dyspnoea203.9%
- 13Constipation193.7%
- 14Gait Disturbance183.5%
- 15Pneumonia183.5%
Literature
Recent PubMed references pinned to Potassium Dichromate as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- Mechanisms of PDC-induced testicular Toxicity: Oxidative stress, steroidogenic suppression, and modulation by ZnO-NP/TEO synergy.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2025 · Morsi AS, Ramadan HM, Youssef AM, et al.PMID 40752661DOI 10.1016/j.fct.2025.115675
- Vitamin C Ameliorates Potassium Dichromate-Induced Oxidative Stress and Mitochondrial Dysfunction via PGC-1α/Nrf-2/TFAM Pathway.Journal of biochemical and molecular toxicology · 2025 · Fatima S, Alrashoudi RH, Alqarni SS, et al.PMID 39714218DOI 10.1002/jbt.70061
- Rutin loaded bilosomes for enhancing the oral activity and nephroprotective effects of rutin in potassium dichromate induced acute nephrotoxicity in rats.Scientific reports · 2024 · Mohsen AM, Wagdi MA, Salama A, et al.PMID 39394242DOI 10.1038/s41598-024-73567-6
- Chlorogenic acid mitigates potassium dichromate-induced acute hepato-nephrotoxicity by attenuating the NF-κB signalling pathway.Molecular biology reports · 2024 · Orhan S, Turkmen R, Demirel HH, et al.PMID 39002019DOI 10.1007/s11033-024-09717-w
- Potassium dichromate sensitivity presenting as tefillin dermatitis: A retrospective cohort study.Contact dermatitis · 2024 · Hilewitz D, Trattner A, Noyman Y, et al.PMID 38923529DOI 10.1111/cod.14627
- Reno-protective effect of nicorandil and pentoxifylline against potassium dichromate-induced acute renal injury via modulation p38MAPK/Nrf2/HO-1 and Notch1/TLR4/NF-κB signaling pathways.Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2024 · El-Shoura EAM, Abdelzaher LA, Ahmed AAN, et al.PMID 38788404DOI 10.1016/j.jtemb.2024.127474
- Bullous Allergic Contact Dermatitis Caused by Potassium Dichromate.Sultan Qaboos University medical journal · 2023 · Navarro-Triviño FJ, Prados-Carmona Á, Velasco-Amador JP, et al.PMID 36865427DOI 10.18295/squmj.5.2022.037
- The Penetration of Chromium: An Up-To-Date 0.5% Potassium Dichromate Vehicle Comparison.Dermatitis : contact, atopic, occupational, drug · 2022 · Linauskiene K, Dahlin J, Ezerinskis Z, et al.PMID 36113002DOI 10.1097/DER.0000000000000805
Clinical trials
The 4 most recently updated of 4 ClinicalTrials.gov registrations naming Potassium Dichromate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Clinical Evaluation of T.R.U.E. Test Allergens in Children an AdolescentsCompleted · Interventional · 116 enrolled · AllerdermNCT01797562updated 2020-08-21
- Effect of the Homeopathic Remedy Kalium Bichromicum (Potassium Dichromate) on Viscosity and Amount of Sputum and Time to Extubation in Mechanically Ventilated ICU Patients.Unknown · Phase 3 · Interventional · 56 enrolled · Shaare Zedek Medical CenterNCT00473473updated 2012-02-22
- Efficacy Study of Homeopathic Potassium Dichromate to Treat Tracheal Secretions in Critically Ill PatientsTerminated · Phase 2 · Interventional · 16 enrolled · Sunnybrook Health Sciences CentreNCT00425633updated 2011-03-25
- Effect of Homeopathic Remedy Kalium Bichromicum on Viscosity and Amount of Sputum Mechanically Ventilated ICU Patients.Unknown · Phase 3 · Interventional · 56 enrolled · Shaare Zedek Medical CenterNCT00326365updated 2007-10-31
Frequently asked questions
- What is Potassium Dichromate used for?
- According to FDA labeling, Potassium Dichromate carries indications including: Uses: Use the leaflet enclosed for detail.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
Note. Data for
potassium-dichromate is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.